Cargando…
Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
Inflammation is a key contributing factor in the pathogenesis of fatty liver diseases (FLD), such as nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver diseases (ALDs). The NLRP3 inflammasome is widely present in the hepatic parenchymal and non-parenchymal cells, which are assembl...
Autores principales: | Liu, Tingting, Xu, Guang, Liang, Longxin, Xiao, Xiaohe, Zhao, Yanling, Bai, Zhaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492967/ https://www.ncbi.nlm.nih.gov/pubmed/36160411 http://dx.doi.org/10.3389/fphar.2022.967594 |
Ejemplares similares
-
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023) -
NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022) -
Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021) -
Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
por: Mu, Wenqing, et al.
Publicado: (2023) -
The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)